| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/13/2002 | EP1179345A1 Anti-inflammatory agents and inhibitors against increase in ocular tension caused by irradiation with lasers, containing 1,4-dihydropyridine derivatives |
| 02/13/2002 | EP1179344A1 Release-regulating preparations |
| 02/13/2002 | EP1179343A1 Remedies for diabetes |
| 02/13/2002 | EP1179342A1 Immediate release medicinal compositions for oral use |
| 02/13/2002 | EP1179341A1 Remedies or preventives for diseases in association with chemokines |
| 02/13/2002 | EP1179338A1 Cosmetic and dermatological compositions comprising cyclodextrines for removing sebum |
| 02/13/2002 | EP1179334A2 Hair tonic for preventing or treating hair loss |
| 02/13/2002 | EP1179184A1 Identifying material from a breast duct |
| 02/13/2002 | EP1179094A2 Assay for the detection of paclitaxel resistant cells in human tumors |
| 02/13/2002 | EP1179090A1 Nucleic acid probe-based diagnostic assays for prokaryotic and eukaryotic organisms |
| 02/13/2002 | EP1179082A2 Improved retroviral production by inhibition of the enveloppe cell receptor |
| 02/13/2002 | EP1179067A1 Neuroprotective properties of gdf-15, a novel member of the tgf-beta superfamily |
| 02/13/2002 | EP1179065A2 Full-length molecules expressed in human tissues |
| 02/13/2002 | EP1179063A2 Genes expressed in hippocampus |
| 02/13/2002 | EP1179062A2 Nucleic acids and proteins with p53 activity and altered tetramerization domains |
| 02/13/2002 | EP1179052A2 Serine proteases |
| 02/13/2002 | EP1179022A2 Bufornin 1 as a specific inhibitor and therapeutic agent for botulinum toxin b and tetanus neurotoxins |
| 02/13/2002 | EP1179005A1 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 02/13/2002 | EP1178999A2 L-ribo-lna analogues |
| 02/13/2002 | EP1178993A1 Thiazoloderiatives and pharmaceutical compositions containing them |
| 02/13/2002 | EP1178990A1 Imidazodiazepine derivative |
| 02/13/2002 | EP1178988A1 Compounds and therapeutic methods |
| 02/13/2002 | EP1178986A2 Furanone derivatives as inhibitors of cathepsin s |
| 02/13/2002 | EP1178984A2 1-trifluoromethyl-4-hydroxy-7-piperidinyl-aminomethylchroman derivatives |
| 02/13/2002 | EP1178983A1 Indole-type derivatives as inhibitors of p38 kinase |
| 02/13/2002 | EP1178982A1 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/13/2002 | EP1178981A1 Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods |
| 02/13/2002 | EP1178977A1 Ion channel modulating agents |
| 02/13/2002 | EP1178973A2 Novel compounds, their use and preparation |
| 02/13/2002 | EP1178971A1 Substituted polycyclic aryl and heteroaryl uracils as anticoagulative agents |
| 02/13/2002 | EP1178970A1 Substituted polycyclic aryl and heteroaryl pyrymidinones useful as anticoagulants |
| 02/13/2002 | EP1178969A1 Gastrin and cholecystokinin receptor ligands |
| 02/13/2002 | EP1178967A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178966A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178965A1 Quinoline derivatives as inhibitors of mek enzymes |
| 02/13/2002 | EP1178964A1 Substituted polycyclic aryl and heteroaryl pyridones useful for selective inhibition of the coagulation cascade |
| 02/13/2002 | EP1178963A1 Ion channel modulating agents |
| 02/13/2002 | EP1178962A1 Process for the preparation of paroxetine acetate and analogues thereof |
| 02/13/2002 | EP1178960A1 Vitamin d analogues and their pharmaceutical use |
| 02/13/2002 | EP1178959A1 Alpha-amino-beta-sulfonyl hydroxamic acid compounds |
| 02/13/2002 | EP1178958A2 N-cyanomethyl amides as protease inhibitors |
| 02/13/2002 | EP1178953A1 Aromatic amides |
| 02/13/2002 | EP1178952A1 NOVEL INTERLEUKIN-1 AND TUMOR NECROSIS FACTOR-$g(a) MODULATORS, SYNTHESES OF SAID MODULATORS AND METHODS OF USING SAID MODULATORS |
| 02/13/2002 | EP1178836A2 Use of chimeric mutational vectors to change endogenous sequences in solid tissues |
| 02/13/2002 | EP1178833A1 Topical compositions for prostaglandin e 1? delivery |
| 02/13/2002 | EP1178832A1 Novel medicament compositions, based on anticholinergically effective compounds and beta-mimetics |
| 02/13/2002 | EP1178831A1 Combined method of treatment comprising an aromatase inhibitor and a further biologically active compound |
| 02/13/2002 | EP1178826A1 Immunotherapy of b-cell malignancies using anti-cd22 antibodies |
| 02/13/2002 | EP1178819A2 Glutathione reductase for therapy and prophylaxis of aids |
| 02/13/2002 | EP1178815A1 Death domain containing receptors |
| 02/13/2002 | EP1178811A1 Electrolyte gels for maintaining hydration and rehydration |
| 02/13/2002 | EP1178810A2 Use of bisphosphonic acids for treating angiogenesis |
| 02/13/2002 | EP1178809A1 Pharmaceutical composition in unit form containing acetylsalcylic acid and clopidogrel hydrogenosulphate |
| 02/13/2002 | EP1178808A1 Pharmaceutical composition |
| 02/13/2002 | EP1178807A2 Use of antiprogestagens in combined therapy |
| 02/13/2002 | EP1178805A1 Novel synthesis and crystallization of piperazine ring-containing compounds |
| 02/13/2002 | EP1178804A2 Use of topical azathioprine to treat inflammatory bowel disorders |
| 02/13/2002 | EP1178803A2 Opioid antagonists containing compositions for enhancing analgesic potency of tramadol and attenuating its adverse side effects |
| 02/13/2002 | EP1178802A1 Cyclic amidines useful as nmda nr2b antagonists |
| 02/13/2002 | EP1178801A2 Combination of nicotinic acid or nicotinamide with riboflavin for the treatment of pruritus, itching and inflammation disorders |
| 02/13/2002 | EP1178800A1 Methods for treating neurodegenerative disorders using aspartyl protease inhibitors |
| 02/13/2002 | EP1178799A1 Microgranules insoluble in gastric fluid, method for obtaining same and pharmaceutical preparations |
| 02/13/2002 | EP1178798A1 Parenteral formulation of 5-(2-chloroethyl)-4-methylthiazole edisylate(clomethiazole edisylate) |
| 02/13/2002 | EP1178797A1 Inhibitors of impdh enzyme |
| 02/13/2002 | EP1178796A1 Salts of aminoimidazole carboxamide useful in the prevention and treatment of liver diseases |
| 02/13/2002 | EP1178795A1 Dfmo and celecoxib in combination for cancer chemoprevention and therapy |
| 02/13/2002 | EP1178794A1 Use of succinic acid derivatives to obtain a medicine for treating inflammation |
| 02/13/2002 | EP1178793A2 Stable solid pharmaceutical compositions containing enalapril maleate |
| 02/13/2002 | EP1178792A1 Aryl amidines, compositions containing such compounds and methods of use |
| 02/13/2002 | EP1178791A2 The use of a protein tyrosine kinase pathway inhibitor in the treatment of ocular disorders |
| 02/13/2002 | EP1178790A1 Treatment to lower platelet adhesiveness |
| 02/13/2002 | EP1178789A1 Method of treating eating disorders |
| 02/13/2002 | EP1178788A1 Novel diphenylethylene compounds |
| 02/13/2002 | EP1178787A1 Pharmaceutical compositions for oral administration of phloroglucinol and preparation thereof |
| 02/13/2002 | EP1178786A1 Protein stabilized pharmacologically active agents, methods for the preparation thereof and methods for the use thereof |
| 02/13/2002 | EP1178784A1 New pharmaceutical combinations for nos inhibitors |
| 02/13/2002 | EP1178783A1 Device and method for increasing the transdermal permeation of medicaments |
| 02/13/2002 | EP1178782A2 Transdermal therapeutic system (tts) containing tolterodine |
| 02/13/2002 | EP1178781A1 Multilayer pharmaceutical product for release in the colon |
| 02/13/2002 | EP1178780A1 Multiparticulate controlled release selective serotonin reuptake inhibitor formulations |
| 02/13/2002 | EP1178776A1 Methods of regulating the condition of mammalian keratinous tissue |
| 02/13/2002 | EP1178774A1 Antiperspirant and deodorant compositions containing cyclohexasiloxane |
| 02/13/2002 | EP1178736A1 A composition containing carvacrol and thymol for use as a bactericide |
| 02/13/2002 | EP1178727A1 A therapeutic mixture useful in inhibiting lesion formation after vascular injury |
| 02/13/2002 | EP1105382B1 Method for the preparation of citalopram |
| 02/13/2002 | EP1049695B1 2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors |
| 02/13/2002 | EP1042320B1 New compounds which are p2-purinoceptor 7-transmembrane (tm) g-protein coupled receptor antagonists |
| 02/13/2002 | EP1019726B1 Prevention of sudden infant death |
| 02/13/2002 | EP1005589A4 Resin-impregnated belt having a texturized outer surface for application on papermaking machines |
| 02/13/2002 | EP0946561B1 Triazolo(4,5-d)pyrimidinyl derivatives and their use as medicaments |
| 02/13/2002 | EP0912591B1 Novel method for isomerising the 10-methyl radical of erythromycin derivatives |
| 02/13/2002 | EP0910345B1 Biconvex rapidly disintegrating dosage forms |
| 02/13/2002 | EP0869942B1 4-((heterocycloalkyl or heteroaromatic)-substituted phenyl]-2-azetidinones useful as hypolipidemic agents |
| 02/13/2002 | EP0861250B1 Amidine and isothiourea derivatives as inhibitors of nitric oxide synthase |
| 02/13/2002 | EP0861236B1 Cyclic and heterocyclic n-substituted alpha-iminohydroxamic and carboxylic acids |
| 02/13/2002 | EP0861081B1 Use of epinastine in the treatment of pain |
| 02/13/2002 | EP0737199B1 Method for preparing concentrated biologically active silicon compounds |
| 02/13/2002 | EP0727997B1 Pharmaceutical emulsion |
| 02/13/2002 | EP0699069B1 Endothelin receptor antagonists |
| 02/13/2002 | EP0594795B1 Michellamines useful as antiviral agents, composition and method of treatment |